Filter
2403
Text search:
immunodeficiency
Featured
Recommendations
239
New Publications
685
Language
Document type
No document type
1598
Guidelines
310
Studies & Reports
278
Manuals
84
Strategic & Response Plan
63
Training Material
41
Fact sheets
13
Situation Updates
6
Brochures
5
Infographics
3
Resource Platforms
1
Online Courses
1
Countries / Regions
India
114
Kenya
102
Ethiopia
68
Tanzania
64
South Africa
64
Nigeria
56
Nepal
55
Global
55
Zambia
49
Malawi
49
Uganda
48
Rwanda
48
Liberia
44
Africa
42
Sierra Leone
40
Namibia
38
Ghana
33
Western and Central Europe
30
Bangladesh
29
Philippines
27
Latin America and the Carribbean
25
Lesotho
23
Ukraine
22
Indonesia
21
Myanmar / Burma
20
Zimbabwe
18
Russia
18
Cambodia
16
South–East Asia Region
16
Asia
16
Burkina Faso
14
Mozambique
14
Eastern Europe
14
Senegal
12
Botswana
12
Eswatini/ Swaziland
11
Congo, Democratic Republic of
10
Haiti
9
Pakistan
9
Germany
9
Tajikistan
9
South Sudan
7
Thailand
7
Benin
7
Georgia
7
Colombia
6
East and Southern Africa
6
Albania
6
Guinea
5
Cameroon
5
Middle East and North Africa
5
Afghanistan
4
Syria
4
Argentina
4
Brazil
4
North Macedonia
4
Paraguay
4
Venezuela
4
Madagascar
3
Eastern Europe and Central Asia
3
Armenia
3
Southern Africa
3
Moldova
3
Côte d’Ivoire / Ivory Coast
2
USA
2
Lebanon
2
China
2
Papua New Guinea
2
Sudan
2
Chile
2
West and Central Africa
2
Timor Leste/ East Timor
2
Estonia
2
Kyrgyzstan
2
North America
2
Morocco
1
Saudi Arabia
1
Somalia
1
Jordan
1
Turkey
1
Central African Republic
1
Peru
1
Switzerland
1
Serbia
1
Hungary
1
Burundi
1
Ecuador
1
El Salvador
1
Mexico
1
Sri Lanka
1
Western Pacific Region
1
Bhutan
1
Poland
1
Laos
1
Romania
1
Iran
1
Uzbekistan
1
Kazakhstan
1
Vietnam
1
Jamaica
1
Belgium
1
Norway
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
1047
Clinical Guidelines
232
Women & Child Health
144
Key Resources
85
Public Health
80
Capacity Building
53
Pharmacy & Technologies
28
Annual Report MEDBOX
1
Toolboxes
HIV
436
TB
289
COVID-19
67
Caregiver
66
Mental Health
55
NTDs
48
AMR
46
Pharmacy
46
Rapid Response
38
Refugee
36
Ebola & Marburg
35
Disability
32
NCDs
24
Conflict
22
2.0 Rapid Response
22
Polio
17
Planetary Health
17
Global Health Education
14
Health Financing Toolbox
14
Malaria
13
Natural Hazards
11
Cholera
7
Zika
6
Specific Hazards
4
South Sudan
1
Accessed: 03.09.2019
PQDx 0141-051-00 WHO
PQDx Public Report
April/2017, version 5.0
PQDx 0005-005-00
WHO PQDx PR
May/2016, version 3.0
Reporting period: January 2014 – December 2014
The human immunodeficiency virus (HIV) epidemic in Myanmar is concentrated among men who have sex with men (MSM), people who inject drugs (PWID) and female sex workers (FSW). HIV prevalence in th ...
The human immunodeficiency virus (HIV) epidemic in Myanmar is concentrated among men who have sex with men (MSM), people who inject drugs (PWID) and female sex workers (FSW). HIV prevalence in th ...
Thirty-three years after its discovery, the Human Immunodeficiency Virus (HIV), responsible for the AIDS pandemic, remains a major public health problem despite advanced researches providing better diagnostic and therapeutic tools. The virus targets
...
In the Indian state of Bihar, visceral leishmaniasis (VL) is a major public health issue that has been aggravated by the rising incidence of new Human immunodeficiency virus (HIV) infections. In endemic areas, the risk of VL infections in patients l
...
In a retrospective review of hospital records of 40 human monkeypox cases from Nigeria, the majority developed fever and self-limiting vesiculopustular skin eruptions. Five deaths
were reported. Compared to human immunodeficiency virus (HIV)–nega
...
Reports of antimicrobial-resistant (AMR) microorganisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for human immunodeficiency
...
Volumen 5 / Número 1 , 1025-1028 • http://www.revistabionatura.com
To describe the behavior of Tuberculosis/Human Immunodeficiency Virus co-infection in a cohort of people affected by sensitive Tuberculosis in Ecuador from 01 January 2010
...
Technical Update
Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates between 1% and 5% (Maps). However, there is limited inf
...
Tuberculosis (TB) is among the top ten most common causes of death globally and as a single infectious disease it top among infectious diseases. Furthermore, it is noted as the top causes of death among people infected with the human immunodeficiency
...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G
...
Zambia has recognised the Public Health threat of antimicrobial resistance and its impact on morbidity and mortality, as well as the subsequent economic consequences. The country has recorded microorganisms which have developed resistance to antimicrobial drugs. Notable among these are; Multidrug Re
...
Colombia is characterized by a fragile and prolonged humanitarian context marked by recurrent multi-hazards affecting its territories and combined with severe structural and systemic challenges within the health system. Recent shocks, including the
COVID-19 pandemic, growing violence within the Col
...
Antimicrobial resistance (AMR) as a serious public health threat was globally acknowledged by WHO in 2015, through the launch of the Global Action Plan (GAP). With a limited number of new antibiotics in the developmental pipeline, many countries are in the process of establishing strategies for anti
...